Hims & Hers Health Price Target Cut to $25.00/Share From $28.00 by Morgan Stanley

What happened

Morgan Stanley cut its price target for Hims & Hers Health to $25.00 per share from $28.00 per share. The supplied report also says Morgan Stanley maintained its Equal-Weight rating on the company.

Confirmed

Global impact / market context

A price target is an analyst’s estimate of a possible share price, not a guarantee. The lower target signals Morgan Stanley sees less potential value than before; the unchanged Equal-Weight rating indicates it did not change its overall recommendation, based on the supplied report.

Analyst inference

The report provides no reasons for the target reduction, company operating updates, or share-price response. Investors therefore cannot tell from this item whether the change reflects revised expectations for revenue, costs, or other factors, or how the market is weighing the analyst’s view.

Confirmed

What to watch

1. Look for any further Morgan Stanley rating or target updates, which could clarify whether this reduction is an isolated change or part of a continuing reassessment. Analyst inference
2. Check for company updates on revenue and costs; changes in those results could help explain whether business expectations support or challenge the lower target. Analyst inference
3. Observe whether the Equal-Weight rating changes in later reports; a different recommendation would show Morgan Stanley has revised its overall view, not just its price estimate. Analyst inference

Evidence

• Original source link unavailable